ArticleThe New England journal of medicine2018
Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin's Lymphoma.
No numbers read from the abstract.
1 paper cites it
2018
this papercites it
ArticleThe New England journal of medicine2018
No numbers read from the abstract.